We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$499M
AUM Growth
-$42.7M
Cap. Flow
-$77M
Cap. Flow %
-15.42%
Top 10 Hldgs %
44.43%
Holding
90
New
18
Increased
19
Reduced
24
Closed
27

Top Buys

Rank Stock Value
1
RAD
Rite Aid Corporation
RAD
+$23.4M
2
NFLX icon
Netflix
NFLX
+$17.6M
3
AGN
Allergan Inc
AGN
+$14.7M
4
MLM icon
Martin Marietta Materials
MLM
+$14.3M
5
VMC icon
Vulcan Materials
VMC
+$13.9M

Top Sells

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$49M
2
BMY icon
Bristol-Myers Squibb
BMY
+$39.2M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$26.4M
4
ENDP
Endo International plc
ENDP
+$15M
5
WDAY icon
Workday
WDAY
+$14M

Sector Composition

Rank Sector Weight
1 Healthcare 32.07%
2 Communication Services 13.58%
3 Materials 10.25%
4 Consumer Discretionary 9.28%
5 Technology 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCR
51
DELISTED
OMNICARE INC
OCR
$680K 0.14%
10,220
-209
-2% -$13K
IPXL
52
DELISTED
Impax Laboratories, Inc.
IPXL
$609K 0.12%
+20,295
New +$547K
BRKR icon
53
Bruker
BRKR
$7.73B
$570K 0.11%
23,487
-4,502
-16% -$97.7K
RPRX
54
DELISTED
Repros Therapeutics Inc.
RPRX
$563K 0.11%
32,535
-11,580
-26% -$189K
ALDR
55
DELISTED
Alder Biopharmaceuticals
ALDR
$560K 0.11%
+27,893
New +$393K
MDCO
56
DELISTED
Medicines Co
MDCO
$526K 0.11%
+18,097
New +$483K
AEGR
57
DELISTED
Aegerion Pharmaceuticals
AEGR
$406K 0.08%
+12,637
New +$471K
ARAV
58
DELISTED
Aravive, Inc. Common Stock
ARAV
$398K 0.08%
+2,367
New +$409K
RVNC
59
DELISTED
Revance Therapeutics, Inc.
RVNC
$303K 0.06%
8,919
-3,671
-29% -$115K
VTRS icon
60
Viatris
VTRS
$20.7B
$290K 0.06%
+5,626
New +$276K
EIGR
61
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$244K 0.05%
34
– –
RCPT
62
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$116K 0.02%
+2,717
New +$93.8K
BLUE
63
DELISTED
bluebird bio
BLUE
– –
-884
Closed -$260K
BMY icon
64
Bristol-Myers Squibb
BMY
$130B
– –
-754,383
Closed -$39.2M
CI icon
65
Cigna
CI
$71.3B
– –
-6,659
Closed -$558K
CRM icon
66
Salesforce
CRM
$158B
– –
-108,923
Closed -$6.22M
CX icon
67
Cemex
CX
$16.8B
– –
-60,182
Closed -$650K
EEM icon
68
iShares MSCI Emerging Markets ETF
EEM
$29.8B
– –
-1,195,800
Closed -$49M
EXPE icon
69
Expedia Group
EXPE
$38.3B
– –
-55,767
Closed -$4.04M
LBTYK icon
70
Liberty Global Class C
LBTYK
$3.53B
– –
-247,977
Closed -$8.17M
MGNX icon
71
MacroGenics
MGNX
$253M
– –
-8,211
Closed -$229K
MYGN icon
72
Myriad Genetics
MYGN
$305M
– –
-1,609
Closed -$55K
PFE icon
73
Pfizer
PFE
$144B
– –
-49,911
Closed -$1.52M
PRTA icon
74
Prothena Corp
PRTA
$449M
– –
-21,273
Closed -$815K
RVTY icon
75
Revvity
RVTY
$12.5B
– –
-4,572
Closed -$206K
1 2
3
4

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q2 2014 Portfolio in Review

As of Q2 2014, Partner Investment Management held 90 positions worth $499M, down 7.9% from $542M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Partner Investment Management withdrew a net $77M in Q2 2014, closing 27 positions and reducing 24 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $49M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 40% a quarter earlier, followed by Communication Services and Materials.

Against the trend, Partner Investment Management opened a new position in Netflix worth $20.5M.

  • Partner Investment Management's largest Q2 2014 buy was Netflix: 3,252,480 shares worth $20.5M.
  • Partner Investment Management added most to Rite Aid Corporation in Q2 2014, an estimated $23.4M increase.
  • Partner Investment Management's biggest Q2 2014 reduction was Alphabet (Google) Class C, cutting an estimated $26.4M.
  • Partner Investment Management fully exited iShares MSCI Emerging Markets ETF in Q2 2014, selling an estimated $49M.
  • Partner Investment Management's ten largest holdings make up 44% of its $499M portfolio in Q2 2014.
  • Partner Investment Management opened 18 new positions and closed 27 in Q2 2014.
  • Partner Investment Management's portfolio value fell 7.9% quarter-over-quarter to $499M.

Based on Partner Investment Management's 13F filing for Q2 2014, filed 14 Aug 2014.